Pre-HTS studies detected a skewed TRBV families distribution in MS peripheral blood (73), clonally expanded CD8+ T-cell clones in MS brain lesions (74), CSF (75, 76) and blood (76). The gene discussed is CD8A; the disease is myeloid sarcoma.